Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial

Zepbound helps shed more weight than Wegovy, Eli Lilly study says

GLP-1 drugs are reshaping the way Americans look at weight loss now that the FDA has approved a few of them to help battle obesity. Now, a new study is shedding light on two of the most popular drugs people turn to to help them shed pounds. In the first head-to-head randomized clinical trial of these drugs, researchers compared results from Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy. It is important to note Eli Lilly funded the study. Previo…

Is Zepbound or Wegovy better for weight loss? New clinical trial reveals which medication sheds more pounds

Zepbound, manufactured by Fortune 500 firm Eli Lilly & Co., bested Wegovy, a product of Global 500 company Novo Nordisk, in a randomized clinical trial.

Battle of the Bulge - Wegovy vs. Zepbound

The Glp-1 battle heats with new preliminary data from Eli Lilly showing that patients using its weight loss drug Zepbound lost more weight on average in 72 weeks than those on Novo Nordisk’s Wegovy. The post Video: Battle of the Bulge – Wegovy vs. Zepbound appeared first on MedCity News.

Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says

Adults on the obesity medication tirzepatide (Zepbound) lost more weight on average than those on semaglutide (Wegovy) in a head-to-head

Ozempic Isn't the No. 1 Treatment for Weight Loss, New Study Finds

If you’ve been debating starting a weight-loss treatment like tirzepatide or semaglutide, you’re going to want to listen closely. In a new trial conducted by Eli Lilly, its tirzepatide injection for weight loss, Zepbound, helped patients drop more pounds than Wegovy, Novo Nordisk's semaglutide injection approved for weight management. Ozempic, which has the same active ingredient as Wegovy, is only approved to treat type 2 diabetes, but it is al…

Weight-loss drugs go head-to-head in new study. One was significantly more effective

In the first head-to-head test, people using Eli Lilly’s Zepbound lost just over 50 pounds while those using competitor Novo Nordisk’s Wegovy shed more than 33 pounds